You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
心通醫療-B(02160.HK):應用AltaValve™及新一代經房間隔輸送系統完成經導管二尖瓣置換手術
格隆匯 05-03 06:24

格隆匯5月3日丨心通醫療-B(02160.HK)發佈公吿,公司的戰略伙伴4C Medical Technologies, Inc.(“4C Medical”)應用其研發的AltaValve™人體經導管二尖瓣置換醫療器械(“AltaValve™)及新一代經房間隔、低外徑、全回收輸送系統(“新一代經房間隔輸送系統”)在希臘雅典成功完成兩例經導管二尖瓣置換(“TMVR”)人道主義手術。

該首批人體臨牀應用手術通過人道主義救助途徑實施。兩位患者被診斷患有嚴重的二尖瓣反流,需要通過治療緩解其引發的心衰症狀。但這兩位患者因身體原因均不適合接受外科手術,且由於他們的心臟解剖結構較為特殊,也不適合其他經導管二尖瓣治療方案。兩例手術均應用新一代經房間隔輸送系統將AltaValve™輸送到指定位置,且二尖瓣反流症狀在術後均顯着降低。目前,患者已出院,術後心臟功能明顯改善,生活質量明顯提升。

AltaValve™是一款TMVR器械,其設計目的為了擴大可治療的病羣:其環上瓣裝置可規避當前已知TMVR技術中存在的錨固和固定困難問題。而且,AltaValve™的設計可最大程度降低其他TMVR裝置可能導致的左心室流出道梗阻的風險。此外,其專有的新一代經房間隔輸送系統可實現AltaValve™的最佳定位和釋放。AltaValve™也是目前已知的全球唯一一款可在完全釋放後輸送系統撤出前實現全回收功能的TMVR器械。公司已對4C Medical進行多輪投資,目前是其第一大股東。公司擁有AltaValve™及新一代經房間隔輸送系統在中國內地、中國香港、中國澳門及中國台灣的獨家商業權利。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account